Search research articles
Contact Us
Filters
Showing results (31-40 of 143) with videos related to
Page
of 15
Sort By:
The Journal of Investigative Dermatology
|
September 1, 1976
The nature of transfer factor and its clinical efficacy in the management of cutaneous disorders
C H Kirkpatrick, T K Smith
Cellular Immunology
|
April 1, 1978
The two-step leukocyte migration inhibition factor (LIF) assay. Its use in evaluation of cellular immune function in patients with immunodeficiency diseases
S W Chapman, C H Kirkpatrick
Journal of Cutaneous Pathology
|
January 1, 1976
Deposition of complement in the lesions of experimental cutaneous candidiasis in guinea pigs
P G Sohnle, C H Kirkpatrick
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1996
Profiles of cytokine production in recipients of transfer factors
L Alvarez-Thull, C H Kirkpatrick
Drugs
|
March 1, 1992
Interferons 1992. How much of the promise has been realised?
M A Volz, C H Kirkpatrick
The Journal of Investigative Dermatology
|
March 1, 1978
Epidermal proliferation in the defense against experimental cutaneous candidiasis
P G Sohnle, C H Kirkpatrick
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1974
Chemotactic activity in dialyzable transfer factor
J I Gallin, C H Kirkpatrick
Transactions of the American Ophthalmological Society
|
January 1, 1973
Immunologic reconstitution in a patient with keratoconjunctivitis, superficial candidiasis and hypoparathyroidism: the role of immunocompetent lymphocyte transfusion and transfer factor
V G Wong, C H Kirkpatrick
Chest Surgery Clinics of North America
|
March 18, 1999
Recognition of the immunocompromised patient
M G Gutierrez, C H Kirkpatrick
Cellular Immunology
|
December 1, 1976
Serial transfer of delayed hypersensitivity with dialyzable transfer factor
C H Kirkpatrick, T K Smith
Page
of 15
Search research articles
Search
Showing results (31-40 of 143) with videos related to
Sort By:
Page
of 15
The Journal of Investigative Dermatology
|
September 1, 1976
The nature of transfer factor and its clinical efficacy in the management of cutaneous disorders
C H Kirkpatrick, T K Smith
Cellular Immunology
|
April 1, 1978
The two-step leukocyte migration inhibition factor (LIF) assay. Its use in evaluation of cellular immune function in patients with immunodeficiency diseases
S W Chapman, C H Kirkpatrick
Journal of Cutaneous Pathology
|
January 1, 1976
Deposition of complement in the lesions of experimental cutaneous candidiasis in guinea pigs
P G Sohnle, C H Kirkpatrick
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1996
Profiles of cytokine production in recipients of transfer factors
L Alvarez-Thull, C H Kirkpatrick
Drugs
|
March 1, 1992
Interferons 1992. How much of the promise has been realised?
M A Volz, C H Kirkpatrick
The Journal of Investigative Dermatology
|
March 1, 1978
Epidermal proliferation in the defense against experimental cutaneous candidiasis
P G Sohnle, C H Kirkpatrick
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1974
Chemotactic activity in dialyzable transfer factor
J I Gallin, C H Kirkpatrick
Transactions of the American Ophthalmological Society
|
January 1, 1973
Immunologic reconstitution in a patient with keratoconjunctivitis, superficial candidiasis and hypoparathyroidism: the role of immunocompetent lymphocyte transfusion and transfer factor
V G Wong, C H Kirkpatrick
Chest Surgery Clinics of North America
|
March 18, 1999
Recognition of the immunocompromised patient
M G Gutierrez, C H Kirkpatrick
Cellular Immunology
|
December 1, 1976
Serial transfer of delayed hypersensitivity with dialyzable transfer factor
C H Kirkpatrick, T K Smith
Page
of 15